IN-DATE
31507: Atrium C-Qur Mesh: 15cm x 15cm
Sign in to add this product to your favorites!
| Price: | $5.65 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 2 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 12 hours 30 minutes and choose overnight shipping at checkout. |
Additional Details
C-QUR™ MESH
C-QUR™ Mesh is indicated for use in hernia repair, chest wall reconstruction, traumatic or surgical wounds, and other fascial surgical intervention procedures requiring reinforcement with a non-absorbable supportive material.
C-QUR™ Mesh combines Atrium’s polypropylene mesh with an all natural Omega 3 gel coating. The O3FA coating is derived from highly purified pharmaceutical grade fish oil consisting of a unique blend of triglycerides and Omega 3 fatty acids.
AccessGUDID Info
- FDA Product Code: FTL
- FDA Product Code Name: Mesh, surgical, polymeric
- GMDN Term Code: 44756
- GMDN Term Name: Extra-gynaecological surgical mesh, composite-polymer
- GMDN Term Description: A partially-bioabsorbable, implantable material (e.g., flat sheet) made of two or more polymers that includes a bioabsorbable polymer [e.g., polyglycolic acid (PGA)] and a non-bioabsorbable polymer [e.g., polyethylene (PE)] intended for extra-gynaecological, non-dental tissue repair/reinforcement application(s) [e.g., pericardial reinforcement, plastic surgery, abdominal hernia repair]. It may also be intended as a short-term scaffold for tissue regeneration. Disposable devices associated with implantation may be supplied with the mesh.
Manufacturer
Atrium (Getinge Group) is a world class organization dedicated to innovation, research and development, state-of-the-art manufacturing, customer service, clinical education, professional marketing and sales, and global logistics. Atrium is a progressive business enterprise that experiences strong employee loyalty and long-term commitment and contributions. However, Atrium’s ambitious growth strategies in an evolving healthcare industry requires a constant pool of talented resources at all levels of the company.
From the cardiac cath-lab to the operating room, Atrium continues to invest in those leading edge technologies that best satisfy our financial goals and contribute to important advancements in patient care. Combining advanced automation with global manufacturing resources, together with extraordinary advances in biomaterial science, our diversified portfolio of critical care products are leading the way to brighter, more clinically effective solutions in cardiovascular disease, soft tissue repair and critical care management.
